Skip to content
buyWeak cluster of 2

Talat Imran bought $20k of RANI

Chief Executive Officer at Rani Therapeutics Holdings, Inc.. 10,296 shares at an average of $1.94, traded Dec 9, 2024, filed Dec 10, 2024.

Conviction score
33
Value
$20k
10,296 shares
Holdings after
494,751
+2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    CEO
    +25
  • Trade size
    $20k at market
    0
  • Relative to holdings
    Holdings up 2.1%
    0
  • Price context
    No price history yet
    0
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -28.4%, 3m -23.2%, 6m -69.3%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

RANIOct 9, 2026 · close 0.80
Since filing Dec 10, 2024: -57.9%SPY +32.1% · excess -90.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000950170-24-134828, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 9, 2024POpen-market purchase
Class A Common Stock
+10,296$1.94$20k494,751Dec 10, 2024

Related signals

Other insiders at Rani Therapeutics Holdings, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
52Moderate
RANIbuy
Rani Therapeutics Holdings, Inc.
Mir A Imran
director, owner
$1.3M
2,083,334 shares
-
57Moderate
RANIsell
Rani Therapeutics Holdings, Inc.
South Cone Investments Limited Partnership
owner
$16M
5,923,000 shares
-71%
36Weak
RANIbuy 2
Rani Therapeutics Holdings, Inc.
Kate McKinley
Chief Business Officer
$30k
17,960 shares
-
47Moderate
RANIsell
Rani Therapeutics Holdings, Inc.
South Cone Investments Limited Partnership
owner
$10M
3,829,360 shares
-32%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Talat Imran bought $20k of RANI | InsiderTell